User profiles for David P Wilson

David Wilson

- Verified email at burnet.edu.au - Cited by 24905

David Wilson

- Verified email at adelaide.edu.au - Cited by 14564

David Wilson

- Verified email at worldbank.org - Cited by 9408

Relation between HIV viral load and infectiousness: a model-based analysis

DP Wilson, MG Law, AE Grulich, DA Cooper, JM Kaldor - The Lancet, 2008 - thelancet.com
Background A consensus statement released on behalf of the Swiss Federal Commission
for HIV/AIDS suggests that people receiving effective antiretroviral therapy—ie, those with …

Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART

…, SC Kippax, JM Kaldor, AE Grulich, DP Wilson - Aids, 2010 - journals.lww.com
Objective: The objective of this study is to estimate per-contact probability of HIV transmission
in homosexual men due to unprotected anal intercourse (UAI) in the era of HAART. Design…

HIV prevalence in China: integration of surveillance data and a systematic review

…, M He, H Sun, X Li, M Gorgens, D Wilson… - The Lancet infectious …, 2013 - thelancet.com
Background Asian HIV epidemics are concentrated among particular behavioural groups,
but large variations exist in epidemic types, timing, and geographical spread between …

[HTML][HTML] Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 …

…, BG Wagner, RG White, DP Wilson… - The Lancet Global …, 2014 - thelancet.com
Background New WHO guidelines recommend initiation of antiretroviral therapy for HIV-positive
adults with CD4 counts of 500 cells per μL or less, a higher threshold than was …

[HTML][HTML] The cost-effectiveness of harm reduction

DP Wilson, B Donald, AJ Shattock, D Wilson… - International Journal of …, 2015 - Elsevier
HIV prevalence worldwide among people who inject drugs (PWID) is around 19%. Harm
reduction for PWID includes needle-syringe programs (NSPs) and opioid substitution therapy (…

Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase …

DP Wilson, M Susnjar, E Kiss, C Sutherland… - Biochemical …, 2005 - portlandpress.com
The signal transduction pathway whereby the TxA 2 (thromboxane A 2 ) mimetic U-46619
activates vascular smooth muscle contraction was investigated in de-endothelialized rat …

Type III secretion a la Chlamydia

J Peters, DP Wilson, G Myers, P Timms, PM Bavoil - Trends in microbiology, 2007 - cell.com
Type III secretion (T3S) is a mechanism that is central to the biology of the Chlamydiaceae
and many other pathogens whose virulence depends on the translocation of toxic effector …

Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase

…, JA MacDonald, JT Deng, DP Wilson… - Biochemical …, 2002 - portlandpress.com
A mechanism proposed for regulation of myosin phosphatase (MP) activity is phosphorylation
of the myosin phosphatase target subunit (MYPT1). Integrin-linked kinase (ILK) is …

The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction

K Swärd, M Mita, DP Wilson, JT Deng… - Current hypertension …, 2003 - Springer
A variety of contractile agonists trigger activation of the small GTPase RhoA. An important
target of activated RhoA in smooth muscle is Rho-associated kinase (ROK), one of the …

[HTML][HTML] Sustainable HIV treatment in Africa through viral-load-informed differentiated care

…, E Bendavid, KJ Nathoo, D Van De Vijver, DP Wilson… - Nature, 2015 - nature.com
There are inefficiencies in current approaches to monitoring patients on antiretroviral
therapy in sub-Saharan Africa. Patients typically attend clinics every 1 to 3 months for clinical …